326030 — SK Biopharmaceuticals Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Market Cap
KR₩8tn
Enterprise Value
KR₩8tn
Revenue
KR₩548bn

Annual balance sheet for SK Biopharmaceuticals Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	387,991	334,339	305,454	241,118	324,489
Net Total Accounts Receivable
Net Total Receivables	12,638	61,675	67,021	115,847	182,436
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	434,603	471,219	487,925	488,722	651,371
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	24,233	22,938	20,350	47,753	43,932
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	500,241	643,652	664,241	723,171	1,036,811
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	70,595	148,306	163,073	241,619	396,276
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	121,175	199,465	347,681	439,484	490,538
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	379,067	444,187	316,560	283,686	546,273
Total Liabilities & Shareholders' Equity	500,241	643,652	664,241	723,171	1,036,811
Total Common Shares Outstanding